Lifesigns Secures Funding from Healthcare Capital to Enhance AI-Powered Patient Monitoring

The funding will help Lifesigns advance its predictive algorithms and enhance its AI capabilities, enabling more accurate and efficient patient monitoring.

Lifesigns, a prominent player in AI-driven patient monitoring, has successfully secured funding from Healthcare Capital, the investment arm of the Kauvery Hospital Group.

This collaboration aims to bolster Lifesigns’ real-time patient monitoring platform, which integrates hardware, software, and artificial intelligence (AI) to deliver early alerts across various healthcare settings, including ambulances, hospitals, and home care.

Additionally, the funding will help Lifesigns advance its predictive algorithms and enhance its AI capabilities, enabling more accurate and efficient patient monitoring. Kauvery Hospital, a long-time partner and early adopter of Lifesigns' innovations, is already using the company's technology.

“This investment from Healthcare Capital is a testament to the trust they place in our technology and its impact on healthcare outcomes,” said Hari Subramaniam, Founder and CEO of Lifesigns.

“With this funding, we aim to push the boundaries of AI-driven patient monitoring, empowering healthcare professionals with predictive tools that enhance decision-making and reduce uncertainty.”

The AI-powered platform, designed to monitor patients in real-time, plays a critical role in improving healthcare efficiency and safety. By providing alerts in real-time, it allows healthcare professionals to intervene promptly and make informed decisions, potentially preventing complications and improving patient outcomes.

Lifesigns is already planning for another funding round in the coming months. This round will support the launch of new technologies and expand its market presence. The strategic investment is expected to accelerate innovation and help Lifesigns strengthen its position in the competitive health tech landscape.